View Future GrowthBluGlass 過去の業績過去 基準チェック /06BluGlassの収益は年間平均-9%の割合で減少していますが、 Semiconductor業界の収益は年間 増加しています。収益は年間3.6% 55.8%割合で 増加しています。主要情報-9.03%収益成長率13.04%EPS成長率Semiconductor 業界の成長27.66%収益成長率55.75%株主資本利益率-130.81%ネット・マージン-159.60%前回の決算情報31 Dec 2025最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • Jun 02BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 5,769,230 Price\Range: AUD 0.26 Transaction Features: Subsequent Direct Listingお知らせ • Apr 15BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,500,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 10,100,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Oct 18BluGlass Limited, Annual General Meeting, Nov 19, 2025BluGlass Limited, Annual General Meeting, Nov 19, 2025. Location: at the offices of automic group, level 5, 126 phillip street, sydney, nsw 2000 Australiaお知らせ • May 01+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 461,538,462 Price\Range: AUD 0.013 Discount Per Security: AUD 0.00026 Security Features: Attached Optionsお知らせ • Sep 20BluGlass Limited, Annual General Meeting, Oct 21, 2024BluGlass Limited, Annual General Meeting, Oct 21, 2024. Location: at automic group offices, at level 5, 126 phillip street, sydney, nsw 2000. Australiaお知らせ • Apr 05BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 157,842,057 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 756,489 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074お知らせ • Feb 20BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,213 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listingお知らせ • Feb 12+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,216 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listingお知らせ • Jan 10BluGlass Limited Announces Management ChangesBluGlass Limited advised that Ms Elizabeth Spooner has resigned as Company Secretary of the Company. Ms Spooner will be replaced by Robyn Slaughter as Company Secretary with effect from 10 January 2024. Robyn is a Company Secretary who works closely with a number of boards of both listed and unlisted public companies across a range of industries including financial services, biotechnology and healthcare, technology, cyber security and manufacturing. Robyn is a qualified Governance Professional (CGI) and Affiliate of the Governance Institute of Australia (GIA), and holds a Master's degree in Corporate Governance and a Bachelor's degree in Accounting and Finance.お知らせ • Sep 13Bluglass Limited Announces Executive ChangesBluGlass Limited has appointed Samuel Samhan as Chief Financial Officer on a full-time basis, effective 11 September 2023. Mr. Samhan is a highly credentialled senior executive with more than 20 years financial leadership and commercial operations experience. He was previously the Chief Operating and Financial Officer at Digital Wellness - a global health platform. Other roles include Head of Commercial and Business Transformation at Vitality Works - Sanitarium Workplace Health and Wellness, and Commercial Manager at Evolution Healthcare Group. He replaces part-time CFO Rob Ambrogio, who resigned from the position to pursue personal projects. To ensure a smooth transition, Mr. Ambrogio will remain with the Company until 29 September 2023. Mr. Samhan holds a Bachelor of Business (Accounting), Master of Business Administration, and is a graduate of the Australian Institute of Company Directors.お知らせ • Sep 08BluGlass Limited, Annual General Meeting, Oct 09, 2023BluGlass Limited, Annual General Meeting, Oct 09, 2023, at 10:01 E. Australia Standard Time. Location: Grant Thornton, Level 17, 383 Kent Street Sydney New South Wales Australia Agenda: To receive and to consider the Annual Financial Report of the Company for the financial year ended 30 June 2023 together with the declaration of the Directors, the Directors' Report, the Remuneration Report and the Auditor's Report for that financial year; to consider Adoption of Remuneration Report; to consider re-election of Directors of the Company; to consider approval of Future Issue of Securities; to consider ratification of Prior Issue of Shares; to consider ratification of Prior Issue of Performance Rights; to consider ratification of Prior Issue of Options; to consider Adoption of Incentive Option & Performance Rights Plan; to consider approval of Issue of Performance Rights to James Walker, Vivek Rao, Stephe Wilks and Jean-Michel Pelaprat Directors of the Company; and to consider approval of Issue of Performance Rights.お知らせ • Jan 30BluGlass Limited Launches Laser Product Suite at Photonics WestBluGlass Limited has launched its first suite of gallium nitride (GaN) laser products for customer purchase at leading industry conference, SPIE Photonics West, in San Francisco, USA. BluGlass' lasers are available across 405nm, 420nm, and 450nm wavelengths in both single-mode and multi-modedevices. Customers can inspect performance data and purchase these products in a range of form factors including TO Cans of different sizes and Chip-on-Submounts. BluGlass' suite of available products have passed entry-level commercial specifications following significant product development, optimisation, and performance and reliability testing. The following products are now available for customer purchase: Violet 405nm multi-mode 1W laser; Violet 405nm single-mode 250mW laser; Violet 420nm multi-mode 1W laser; Violet 420nm single-mode 250mW laser; Blue 450nm multi-mode 1W laser; Blue 450nm single-mode 100mW laser. The Company has received interest from customers wanting to deploy BluGlass lasers in their product development programs, which span a multitude of applications including; 3D printing, quantum sensing and computing, material sensing, and flow cytometry. In addition to the launched products, laser diode designs in other wavelengths and specifications are progressing through BluGlass' supply chain, including RPCVD-enhanced products.収支内訳BluGlass の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:BUGL.F 収益、費用、利益 ( )AUD Millions日付収益収益G+A経費研究開発費31 Dec 256-913030 Sep 256-1013030 Jun 255-1113031 Mar 256-1112031 Dec 246-1012030 Sep 245-1012030 Jun 245-1011031 Mar 243-1111031 Dec 232-1211030 Sep 231-1210030 Jun 231-1210031 Mar 231-119031 Dec 221-108030 Sep 221-107030 Jun 221-96031 Mar 220-85031 Dec 210-74030 Sep 210-74030 Jun 210-64031 Mar 210-65031 Dec 200-75030 Sep 201-65030 Jun 201-66031 Mar 201-106031 Dec 191-156030 Sep 191-155030 Jun 190-145031 Mar 191-105031 Dec 181-55-130 Sep 181-44030 Jun 181-44031 Mar 181-44031 Dec 171-44030 Sep 171-44030 Jun 171-44031 Mar 170-44031 Dec 16-1-44030 Sep 160-44030 Jun 160-34031 Mar 160-34031 Dec 150-34030 Sep 150-340質の高い収益: BUGL.Fは現在利益が出ていません。利益率の向上: BUGL.Fは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: BUGL.Fは利益が出ておらず、過去 5 年間で損失は年間9%の割合で増加しています。成長の加速: BUGL.Fの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: BUGL.Fは利益が出ていないため、過去 1 年間の収益成長をSemiconductor業界 ( 22.6% ) と比較することは困難です。株主資本利益率高いROE: BUGL.Fは現在利益が出ていないため、自己資本利益率 ( -130.81% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YSemiconductors 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/08 01:18終値2026/07/06 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋BluGlass Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Mark BryanCanaccord Genuity Historic (Wilsons Advisory and Stockbroking Ltd.Darren VincentShaw and Partners Limited
お知らせ • Jun 02BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 5,769,230 Price\Range: AUD 0.26 Transaction Features: Subsequent Direct Listing
お知らせ • Apr 15BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,500,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 10,100,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Oct 18BluGlass Limited, Annual General Meeting, Nov 19, 2025BluGlass Limited, Annual General Meeting, Nov 19, 2025. Location: at the offices of automic group, level 5, 126 phillip street, sydney, nsw 2000 Australia
お知らせ • May 01+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 461,538,462 Price\Range: AUD 0.013 Discount Per Security: AUD 0.00026 Security Features: Attached Options
お知らせ • Sep 20BluGlass Limited, Annual General Meeting, Oct 21, 2024BluGlass Limited, Annual General Meeting, Oct 21, 2024. Location: at automic group offices, at level 5, 126 phillip street, sydney, nsw 2000. Australia
お知らせ • Apr 05BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 157,842,057 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 756,489 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074
お知らせ • Feb 20BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,213 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listing
お知らせ • Feb 12+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,216 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listing
お知らせ • Jan 10BluGlass Limited Announces Management ChangesBluGlass Limited advised that Ms Elizabeth Spooner has resigned as Company Secretary of the Company. Ms Spooner will be replaced by Robyn Slaughter as Company Secretary with effect from 10 January 2024. Robyn is a Company Secretary who works closely with a number of boards of both listed and unlisted public companies across a range of industries including financial services, biotechnology and healthcare, technology, cyber security and manufacturing. Robyn is a qualified Governance Professional (CGI) and Affiliate of the Governance Institute of Australia (GIA), and holds a Master's degree in Corporate Governance and a Bachelor's degree in Accounting and Finance.
お知らせ • Sep 13Bluglass Limited Announces Executive ChangesBluGlass Limited has appointed Samuel Samhan as Chief Financial Officer on a full-time basis, effective 11 September 2023. Mr. Samhan is a highly credentialled senior executive with more than 20 years financial leadership and commercial operations experience. He was previously the Chief Operating and Financial Officer at Digital Wellness - a global health platform. Other roles include Head of Commercial and Business Transformation at Vitality Works - Sanitarium Workplace Health and Wellness, and Commercial Manager at Evolution Healthcare Group. He replaces part-time CFO Rob Ambrogio, who resigned from the position to pursue personal projects. To ensure a smooth transition, Mr. Ambrogio will remain with the Company until 29 September 2023. Mr. Samhan holds a Bachelor of Business (Accounting), Master of Business Administration, and is a graduate of the Australian Institute of Company Directors.
お知らせ • Sep 08BluGlass Limited, Annual General Meeting, Oct 09, 2023BluGlass Limited, Annual General Meeting, Oct 09, 2023, at 10:01 E. Australia Standard Time. Location: Grant Thornton, Level 17, 383 Kent Street Sydney New South Wales Australia Agenda: To receive and to consider the Annual Financial Report of the Company for the financial year ended 30 June 2023 together with the declaration of the Directors, the Directors' Report, the Remuneration Report and the Auditor's Report for that financial year; to consider Adoption of Remuneration Report; to consider re-election of Directors of the Company; to consider approval of Future Issue of Securities; to consider ratification of Prior Issue of Shares; to consider ratification of Prior Issue of Performance Rights; to consider ratification of Prior Issue of Options; to consider Adoption of Incentive Option & Performance Rights Plan; to consider approval of Issue of Performance Rights to James Walker, Vivek Rao, Stephe Wilks and Jean-Michel Pelaprat Directors of the Company; and to consider approval of Issue of Performance Rights.
お知らせ • Jan 30BluGlass Limited Launches Laser Product Suite at Photonics WestBluGlass Limited has launched its first suite of gallium nitride (GaN) laser products for customer purchase at leading industry conference, SPIE Photonics West, in San Francisco, USA. BluGlass' lasers are available across 405nm, 420nm, and 450nm wavelengths in both single-mode and multi-modedevices. Customers can inspect performance data and purchase these products in a range of form factors including TO Cans of different sizes and Chip-on-Submounts. BluGlass' suite of available products have passed entry-level commercial specifications following significant product development, optimisation, and performance and reliability testing. The following products are now available for customer purchase: Violet 405nm multi-mode 1W laser; Violet 405nm single-mode 250mW laser; Violet 420nm multi-mode 1W laser; Violet 420nm single-mode 250mW laser; Blue 450nm multi-mode 1W laser; Blue 450nm single-mode 100mW laser. The Company has received interest from customers wanting to deploy BluGlass lasers in their product development programs, which span a multitude of applications including; 3D printing, quantum sensing and computing, material sensing, and flow cytometry. In addition to the launched products, laser diode designs in other wavelengths and specifications are progressing through BluGlass' supply chain, including RPCVD-enhanced products.